ADIPOQ and obesity disorder: Blood concentrations of adiponectin are significantly decreased in obesity, diabetes, hypertension, and coronary arteries disorder in human and experimentally induced models of insulin resistance and diabetes in animals through agonist of AdipoRs to treat the type 2 DM obese mouse model.